What Happened
In a breakthrough for vision correction, researchers have developed a method that reshapes the eye without lasers or incisions. Using mild electrical pulses and platinum contact lenses, they temporarily soften the cornea so it can be molded into a new shape. Early tests on rabbit eyes successfully corrected nearsightedness in about a minute while preserving the eye's structure.
Meanwhile, in the Democratic Republic of the Congo, the World Health Organization (WHO) Director-General, Tedros Adhanom Ghebreyesus, addressed the people of the country on the ongoing Ebola outbreak. In a personal message, he expressed his solidarity with the affected communities and acknowledged the bravery of health workers risking their lives to combat the disease.
Why It Matters
The new vision correction method has the potential to revolutionize eye care, providing a safer and cheaper alternative to LASIK surgery. As WHO Director-General Tedros noted, "Ebola is not new to me personally," highlighting the ongoing need for effective disease response strategies.
What Experts Say
"The norm-shattering masks a more fundamental misunderstanding of how administrative power can bring about lasting change," writes Joshua Sharfstein, commenting on Marty Makary's views on the FDA.
Eric Topol, a prominent expert on longevity, notes that "there's been interest in longevity, promoting it, for millennia. But this 25-year campaign really brought it to the forefront," referring to the concept of "blue zones."
Key Numbers
- ****$3.2 billion:** The estimated global market size for vision correction treatments by 2025
Key Facts
- What: Developed a new vision correction method without lasers or surgery
- Where: The Democratic Republic of the Congo (Ebola outbreak)
What Comes Next
As the new vision correction method undergoes further testing, and the WHO continues to address the Ebola outbreak, experts will be watching for the implications of these developments on global health and eye care. The FDA's role in regulating new medical technologies will also be under scrutiny, as experts debate the best approaches to promoting longevity and well-being.
What Happened
In a breakthrough for vision correction, researchers have developed a method that reshapes the eye without lasers or incisions. Using mild electrical pulses and platinum contact lenses, they temporarily soften the cornea so it can be molded into a new shape. Early tests on rabbit eyes successfully corrected nearsightedness in about a minute while preserving the eye's structure.
Meanwhile, in the Democratic Republic of the Congo, the World Health Organization (WHO) Director-General, Tedros Adhanom Ghebreyesus, addressed the people of the country on the ongoing Ebola outbreak. In a personal message, he expressed his solidarity with the affected communities and acknowledged the bravery of health workers risking their lives to combat the disease.
Why It Matters
The new vision correction method has the potential to revolutionize eye care, providing a safer and cheaper alternative to LASIK surgery. As WHO Director-General Tedros noted, "Ebola is not new to me personally," highlighting the ongoing need for effective disease response strategies.
What Experts Say
"The norm-shattering masks a more fundamental misunderstanding of how administrative power can bring about lasting change," writes Joshua Sharfstein, commenting on Marty Makary's views on the FDA.
Eric Topol, a prominent expert on longevity, notes that "there's been interest in longevity, promoting it, for millennia. But this 25-year campaign really brought it to the forefront," referring to the concept of "blue zones."
Key Numbers
- ****$3.2 billion:** The estimated global market size for vision correction treatments by 2025
Key Facts
- What: Developed a new vision correction method without lasers or surgery
- Where: The Democratic Republic of the Congo (Ebola outbreak)
What Comes Next
As the new vision correction method undergoes further testing, and the WHO continues to address the Ebola outbreak, experts will be watching for the implications of these developments on global health and eye care. The FDA's role in regulating new medical technologies will also be under scrutiny, as experts debate the best approaches to promoting longevity and well-being.